Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion [1]

British Journal of Haematology

Volumn 138, Issue 2, 2007, Pages 271-275

  Wang, Sa A ^a   Yue, Gang ^a   Hutchinson, Lloyd ^a   Landry, Marie L ^b   Hasserjian, Robert P ^c   Hao, Suyang ^a   Galili, Naomi ^d   Raza, Azra ^d   Woda, Bruce A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Immunuosuppressant; Myelodysplastic syndrome; Parvovirus B19; Pure red cell aplasia; T cell clonality

Indexed keywords

ALEMTUZUMAB; AZACITIDINE; CYCLOSPORIN; DEXAMETHASONE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PREDNISONE; THALIDOMIDE;

ADULT; AGED; BONE MARROW; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE APLASIA; FEMALE; HEMATOPOIESIS; HUMAN; LETTER; MALE; MYELODYSPLASTIC SYNDROME; PARVOVIRUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PARVOVIRUS B19, HUMAN; RED-CELL APLASIA, PURE;

EID: 34250835964     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06648.x     Document Type: Letter

References (10)

1. Garcia-Suarez, J., Pascual, T., Munoz, M.A., Herrero, B. Pardo, A. (1998) Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature. American Journal of Hematology, 58, 319 325.
2. Jordan, J.A., Faas, S.J., Braun, E.R. Trucco, M. (1996) Exonuclease-released fluorescence detection of human parvovirus B19 DNA. Molecular Diagnosis, 1, 321 328.
3. Ogata, M., Ohtsuka, E., Imamura, T., Ikewaki, J., Ogata, Y., Kohno, K., Nakayama, T., Ono, K., Saburi, Y., Kikuchi, H. Nasu, M. (2004) Response to cyclosporine therapy in patients with myelodysplastic syndrome: a clinical study of 12 cases and literature review. International Journal of Hematology, 80, 35 42.
4. Okamoto, T., Okada, M., Yamada, S., Takatsuka, H., Wada, H., Tamura, A., Fujimora, Y., Takemoto, Y. Kakishita, E. (2000) Good response to cyclosporine therapy in patients with myelodysplastic syndromes having the HLA-DRB1*1501 allele. Leukemia, 14, 344 346.
5. Park, S., Merlat, A., Guesnu, M., Picard, F., Viguie, F., Vassilieff, D. Dreyfus, F. (2000) Pure red cell aplasia associated with myelodysplastic syndromes. Leukemia, 14, 1709 1710.
6. Preudhomme, C., Vachee, A., Morshauser, F., Henic, N., Cosson, A. Fenaux, P. (1994) Immunoglobulin and T-cell receptor gamma gene rearrangements are rarely found in myelodysplastic syndromes in chronic phase. Leukemia Research, 18, 365 371.
7. Shimamoto, T., Iguchi, T., Ando, K., Katagiri, T., Tauchi, T., Ito, Y., Yaguchi, M., Miyazawa, K., Kimura, Y., Masuda, M., Mizoguchi, H. Ohyashiki, K. (2001) Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. British Journal Haematology, 114, 358 361.
8. Takata, S., Kojima, K., Fujii, N., Kaneda, K., Yoshida, C., Hashimoto, D., Asakura, S., Shinagawa, K. Tanimoto, M. (2003) Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22). Cancer Genetics Cytogenetics, 140, 167 169.
9. Williamson, P.J., Oscier, D.G., Bell, A.J. Hamblin, T.J. (1991) Red cell aplasia in myelodysplastic syndrome. Journal of Clinical Pathology, 44, 431 432.
10. Wlodarski, M.W., Gondek, L.P., Nearman, Z.P., Plasilova, M., Kalaycio, M., His, E.D. Maciejewski, J.P. (2006) Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome. Blood, 108, 2632 2641.